Back to Mason Hawkins
Mason Hawkins → REGN via SOUTHEASTERN ASSET MANAGEMENT INC/TN/
Mason Hawkins REGN Position History
Regeneron Pharmaceuticals, Inc. • Healthcare
Quarters held
12
Latest value
$82.8M
Q2 2026
Peak value
$107M
First seen
Q1 2025
Quarter-by-quarter history
Every disclosed snapshot
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $82.8M | 132.8K | — | — |
| Q2 2026 | $12.2M | 19.5K | — | — |
| Q1 2026 | $82.5M | 106.8K | — | — |
| Q1 2026 | $18.4M | 23.9K | — | — |
| Q4 2025 | $107M | 138.6K | — | — |
| Q4 2025 | $21M | 27.2K | — | — |
| Q3 2025 | $66M | 117.3K | — | — |
| Q3 2025 | $15.3M | 27.3K | — | — |
| Q2 2025 | $68.6M | 130.7K | — | — |
| Q2 2025 | $15.7M | 29.9K | — | — |
| Q1 2025 | $58.6M | 92.4K | — | — |
| Q1 2025 | $14.3M | 22.5K | — | — |